Neuwelt, A J
Cabozantinib use in renal cell carcinoma. [electronic resource]
- Drugs of today (Barcelona, Spain : 1998) May 2017
- 299-307 p. digital
Publication Type: Journal Article; Review
1699-3993
10.1358/dot.2017.53.5.2623107 doi
Anilides--adverse effects
Animals
Antineoplastic Agents--adverse effects
Carcinoma, Renal Cell--drug therapy
Drug Interactions
Humans
Kidney Neoplasms--drug therapy
Protein Kinase Inhibitors--adverse effects
Proto-Oncogene Mas
Pyridines--adverse effects
Treatment Outcome